Global Medical Devices Mergers and Acquisitions (M&A) Deals Overview Report, Q3 2021: A Drop of 38% in Deal Value to $52 Billion and 18% in Deal Volume Terms
Dublin, Nov. 25, 2021 (GLOBE NEWSWIRE) -- The "Global Mergers and Acquisitions (M&A) Deals in Q3 2021 - Top Themes in the Medical Devices Sector - Thematic Research" report has been added to ResearchAndMarkets.com's offering.
This report analyzes the disruptive themes that have driven M&A activity in Q3 2021 in Medical Devices Sector.
M&A deals in Q3 2021 recorded a drop of 38% in deal value (to $52 billion) and 18% in deal volume terms, compared to the previous quarter. However, when compared to the deal activity in Q3 2020, both deal value and volume were consistent.
Scope
This report provides an overview of merger and acquisition activity globally in Q3 2021 in Medical Devices Sector.
It identifies the themes driving most notable to deals announced in Q3 2021 in the Medical Devices Sector.
Reasons to Buy
Companies who invest in the right themes become success stories; those who miss the big themes end up as failures. If you want to understand the themes that drive an industry, simply look at the list of recent mergers and acquisitions (M&A).
In this report we have listed down the most notable deals in Medical Devices sector to make it easy for our clients to get a view of themes disrupting the sector and prepare for the future.
Key Topics Covered:
Global M&A deals in Q3 2021 - Key takeaways
Review of global M&A deals in Q3 2021
Themes driving global M&A deals in Q3 2021
Appendices
Companies Mentioned
Sigma Healthcare
Australian Pharmaceutical
GE Healthcare
BK Medical Systems
Boston Scientific
Devoro Medical
Mesa Laboratories
Agena Bioscience
Agiliti Health
Sizewise Rentals
Zoll Medical
Itamar Medical
ICU Medical
Smiths Group
planmeca Verwaltungs
Envista
Cardio Partners
Allied 100
Baxter
Hill-Rom
Nordic Capital
22C Capital
Insight Partners
Inovalon
Hibercell
Genuity Science
Nano-X Imaging
Zebra Medical Vision
Medtronic
Intersect ENT
Trulli Bidco
Smiths Medical
Bioventus
Misonix
Surgical Science
Simbionix
EQT Partners
Lifebrain
Pacific Biosciences of California
Omniome
HeartFlow
Longview acquisition
For more information about this report visit https://www.researchandmarkets.com/r/veyfdr
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900